Early Warning Press Release in Accordance With National Instrument 62-103
Early Warning Press Release in Accordance With National Instrument 62-103
Vancouver, British Columbia--(Newsfile Corp. - April 4, 2024) - Cathay Visions Enterprises Ltd. (the "Acquiror") acquired 110,000 common shares (each a "Common Share") of Optimi Health Corp. (the "Issuer") pursuant to acquisitions in the public market. The Common Shares of the Issuer are listed on the CSE under the trading symbol "OPTI".
不列顛哥倫比亞省溫哥華--(Newsfile Corp.,2024 年 4 月 4 日)-國泰願景企業有限公司(”收購者“) 收購了 110,000 股普通股(每股 a)”常見 分享“) 的 Optimi Health Corp.(”發行人“)根據公開市場的收購。發行人的普通股在CSE上市,交易代碼爲 “OPTI”。
Prior to giving effect to the foregoing acquisition of Common Shares, the Acquiror owned and/or had control over an aggregate of 8,875,483 Common Shares, representing approximately 9.96% of the issued and outstanding Common Shares of the Issuer on an undiluted basis. Following completion of the acquisition of the Common Shares, the Acquiror owns or has control or direction over, directly or indirectly, 8,985,483 Common Shares, 166,666 warrants, 450,000 stock options and 15,750 restricted share rights, representing approximately 10.09% of the issued and outstanding Common Shares of the Issuer on an undiluted basis and approximately 10.72% of the total issued and outstanding Common Shares of the Issuer on a partially diluted basis.
在上述普通股收購生效之前,收購方共擁有和/或控制了8,875,483股普通股,約佔發行人未稀釋已發行和流通普通股的9.96%。普通股收購完成後,收購方直接或間接擁有或控制或指導8,985,483股普通股、166,666份認股權證、45萬股股票期權和15,750股限制性股權,約佔發行人未稀釋已發行和流通普通股的10.09%,部分攤薄後佔發行人已發行和流通普通股總額的10.72% 基礎。
The Acquiror may acquire additional securities or dispose of securities of the Issuer in the future either on the open market, privately or otherwise depending on market conditions, reformulation of plans, other available investment business opportunities and/or other relevant factors.
根據市場狀況、計劃的重新制定、其他可用的投資商業機會和/或其他相關因素,收購方將來可以在公開市場上、私下或其他方式收購更多證券或處置發行人的證券。
For further information or to receive a copy of the early warning report filed by the Acquiror with securities regulatory authorities in Canada in connection with this press release, please contact Leah Hodges at (604) 377-0403 or refer to the Issuer's SEDAR+ profile at .
欲了解更多信息或獲取收購方就本新聞稿向加拿大證券監管機構提交的預警報告的副本,請致電 (604) 377-0403 與 Leah Hodges 聯繫,或參閱發行人的SEDAR+簡介,網址爲。
譯文內容由第三人軟體翻譯。